Results 41 to 50 of about 129,727 (305)

Central Obesity and BMI Associated with Different Phenotypes of Polycystic Ovary Syndrome in Adolescent [PDF]

open access: yes, 2017
Adipose tissue distribution is effective in metabolic complications resulting from obesity. Fat accumulation in the body, particularly increase in visceral fat, is a major risk factor of diabetes and cardiovascular diseases.
Akbaezadeh, M. (Marzieh)   +1 more
core   +3 more sources

The impact of female obesity on the outcome of fertility treatment [PDF]

open access: yes, 2010
Peer reviewedPublisher ...
Abha Maheshwari   +53 more
core   +3 more sources

Uncovering anorexia nervosa in a biofeedback clinic for bowel dysfunction [PDF]

open access: yes, 2012
Biofeedback is a conservative treatment based on behavioural techniques, which can be used in the management of bowel dysfunction. This article reports the results of a retrospective review of the clinical notes of 87 female patients attending a ...
Chelvanayagam, Sonya   +3 more
core   +1 more source

Polycystic ovaries and polycystic ovary syndrome

open access: yesGynecological Endocrinology, 1987
In the 50 years or so since the description by Irving F. Stein and Michael L. Leventhal of their finding of unexpectedly enlarged ovaries in a group of women with amenorrhea1, the syndrome we associate with their names has become widely recognized, variously interpreted and a subject of continual fascination for scores of reproductive scientists and ...
openaire   +2 more sources

Anti-mullerian hormone and antral follicle count in polycystic ovary syndrome and non-polycystic ovary syndrome women

open access: yesZanco Journal of Medical Sciences, 2019
Background and objective: Although the ultimate pathogenesis of polycystic ovary syndrome remains obscure, the distinctive feature is the failure of follicular maturation resulting in an ovulation and accumulation of preantral and small antral follicles ...
Jwan J. Namik   +2 more
doaj   +1 more source

Consensus on infertility management and fertility preservation related to polycystic ovary syndrome

open access: yesReproductive and Developmental Medicine, 2020
There is currently no universally accepted unified diagnostic standard for infertility treatment and maternity protection related to polycystic ovary syndrome (PCOS) worldwide, and the treatment options vary greatly.
Expert Group of Consensus on Infertility Managemen and Fertility Preservation Related to Polycystic Ovary Syndrome
doaj   +1 more source

Nutritional Management in Polycystic Ovary Syndrome: Challenges and opportunities [PDF]

open access: yes, 2021
PCOS is one of the most common endocrine diseases affecting women of reproductive age. Its etiology remains unresolved but it is thought to have a genetic basis as well as interactions with other environmental factors.
Ghazeeri, G.   +5 more
core   +1 more source

Hyperandrogenemia Induces Trophoblast Ferroptosis and Early Pregnancy Loss in Patients With PCOS via CMA‐Dependent FTH1 Degradation

open access: yesAdvanced Science, EarlyView.
In PCOS patients with hyperandrogenemia, decreased ferritin heavy chain 1 (FTH1) causes Fe2⁺ overload and ferroptosis in trophoblasts. Androgens induce FTH1 protein degradation via AR‐LAMP2A‐mediated chaperone‐mediated autophagy pathway, leading to placental development disruption and early pregnancy loss. Metformin mitigates androgen‐induced placental
Hanjing Zhou   +10 more
wiley   +1 more source

‘Everything’s from the inside out with PCOS’: Exploring women’s experiences of living with polycystic ovary syndrome and co-morbidities through Skype™ interviews

open access: yesHealth Psychology Open, 2015
Polycystic ovary syndrome is an endocrine disorder affecting 1 in 10 women. Women with polycystic ovary syndrome can experience co-morbidities, including depressive symptoms.
Sophie Williams   +2 more
doaj   +1 more source

The experiences of women with polycystic ovary syndrome on a very low-calorie diet [PDF]

open access: yes, 2016
The research was funded by an educational grant from LighterLife. Broom was the Medical Director for LighterLife at the time of the research. Johnson is the Head of Nutrition and Research at LighterLife.
Broom, John   +5 more
core   +3 more sources

Home - About - Disclaimer - Privacy